Counsyl Stock

Health Technology Company

Sign up today and learn more about Counsyl Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Goldman Sachs


South San Francisco CA, US

Total Funding


About Counsyl Stock

Counsyl is a genetic screening and counseling services company. The company provides women and their families with actionable information to guide health decisions. Counsyl operates a clinical laboratory that offers the Foresight™ Carrier Screen, Prelude™ Prenatal Screen and Reliant™ Cancer Screen, and supporting services through Counsyl Complete™, a proprietary suite of solutions, each designed to integrate into clinic workflows and patients’ lives. Their genetic screens provide actionable information to patients and their healthcare providers through process that facilitates clinical decision-making.

The company launched their first commercial screen in 2009, and in January 2018, reached a milestone of having delivered one million patient results.

How Counsyl Works

Source: Counsyl


Funding History

June 2010$7.5M
November 2011$36.1M
August 2012$8.2M
May 2014$50.0M


Co-Founder & Chief Executive Officer

Ramji Srinivasan

Co-Founder & Chief Science Officer

Eric Evans

Chief Medical Officer

James Goldberg, PhD

Chief Financial Officer

Joel Jung

Chief Commercial Officer

Noah Nasser

Co-Founder & SVP, Technology

Rishi Kacker


Business Wire (press release) - Jan, 30 2018

Counsyl Surpasses One Million Genetic Screens

Business Wire (press release) - Jan, 16 2018

Counsyl Secures Approval From New York State Department of ...

Business Wire (press release) - Dec, 14 2017

Counsyl Appoints Pamela Sedmak to Board of Directors

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: